Cabergoline therapy for Macroprolactinoma during pregnancy: A case report [PDF]
BMC Research Notes, 2012 Background We assessed the safety of Cabergoline therapy during pregnancy in a lady with hyperprolactinemia intolerant to Bromocriptine. Case presentation We report the case of a 31 year old lady who presented to us with uncontrolled hyperprolactinemia ...
Shahzad Hira +2 more
doaj +3 more sources
Long-Term Results of Cabergoline Add-on Long-Acting Somatostatin Analogue Therapy in Acromegaly Patients [PDF]
Gazi Medical JournalObjective: To investigate the efficacy of the dopamine agonist cabergoline in uncontrolled acromegaly despite long-acting somatostatin analog (SSA). Methods: Thirty-five patients with acromegaly who were followed up in the department of endocrinology ...
Mehmet Muhittin Yalçın +13 more
doaj +3 more sources
Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma [PDF]
Indian Journal of Endocrinology and Metabolism, 2017 Background: Clinical relevance of association of cabergoline use for hyperprolactinemia and cardiac valvulopathy remains unclear. Objective: The aim of the study was to determine the prevalence of valvular heart abnormalities in patients taking ...
Shruti Khare +6 more
doaj +2 more sources
Cabergoline-induced tricuspid regurgitation: Case report and review of literature [PDF]
Indian Journal of Endocrinology and Metabolism, 2011 The increased risk of cardiac valve disease in patients treated for Parkinson′s disease with cabergoline has raised concerns about the safety of treatment with ergot-derived dopamine agonists in patients with endocrine diseases, especially prolactinoma ...
Mohammad Hayat Bhat +4 more
doaj +2 more sources
Cabergoline-induced mania in a patient of pituitary microadenoma [PDF]
Indian Journal of Psychological Medicine, 2017 Cabergoline, a dopamine agonist agent, is commonly used in the treatment of hyperprolactinemia, Parkinson's disease, restless leg syndrome, and antipsychotic-induced prolactin elevation.
Satyakam Mohapatra, Mihir Ranjan Nayak
doaj +2 more sources
A retrospective drug use evaluation of cabergoline for lactation inhibition at a tertiary care teaching hospital in Qatar [PDF]
Therapeutics and Clinical Risk Management, 2016 Doua AlSaad,1 Samah ElSalem,1 Palli Valapila Abdulrouf,1 Binny Thomas,1,2 Tayseer Alsaad,3 Afif Ahmed,1 Moza AlHail4 1Department of Pharmacy, Women’s Hospital, Hamad Medical Corporation, Doha, Qatar; 2Department of Pharmacy and Life Sciences ...
AlSaad D +6 more
doaj +1 more source
Giant prolactinoma case with side effects due to cabergoline [PDF]
, 2020 Dopamine agonists should usually be the first treatment for patients with prolactinomas of all sizes, because these drugs decrease serum prolactin concentrations and decrease the size of most lactotroph adenomas. Cabergoline is preferred first.
Hüseyin Dursun +3 more
core +1 more source
Cabergoline Treatment in Invasive Giant Prolactinoma [PDF]
, 2014 Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive
Sadeem Alsubaie, Mussa H. Almalki
core +1 more source
Dopamine D2 Receptor Agonists as Modulators of VEGF-A-Driven Angiogenesis: Mechanisms, Clinical Evidence, and Translational Opportunities. [PDF]
FASEB JInterplay between VEGF‐A‐driven angiogenesis and DRD2‐mediated inhibition. Tumor‐derived VEGF‐A activates VEGFR2 on endothelial cells, triggering proangiogenic signaling pathways that promote abnormal vessel growth and vascular leakage. VEGF‐A also induces DRD2 expression, establishing a feedback mechanism.
Akkanapally V +6 more
europepmc +2 more sources
Thyrotropin-secreting pituitary tumor presenting with congestive heart failure and good response to dopaminergic agonist cabergoline [PDF]
, 2014 Hyperthyroidism is an important inducing factor in patients with atrial fibrillation, and may trigger heart failure. Thyrotropin (thyroid stimulating hormone, TSH)-secreting pituitary tumors are rare causes of hyperthyroidism.
黃天祥 ;張恬君 +1 more
core +1 more source